We observed T cell activation against CCRFSB, NALM6, HPB-ALL, SKW3 but not OCIM1 (Figures 5C, D), and specificity was confirmed by almost complete blockade in the presence of the L161 anti-CD1c antibody (Supplementary Figures S5G, H). Here, CD1C is linked to acute lymphoblastic leukemia.